928250827	928250827	CD	B-NP	O
|	|	JJ	I-NP	O
S	S	NN	I-NP	O
|	|	NN	I-NP	O
57266058	57266058	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3283086	3283086	CD	B-NP	O
|	|	CC	I-NP	O
8/14/2006	8/14/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/27/2006	10/27/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NN	B-NP	O
:	:	:	O	O
RAGSDALE	RAGSDALE	NN	B-NP	O
,	,	,	O	O
NATHANAEL	NATHANAEL	NNP	B-NP	O
DALE	DALE	NNP	I-NP	O
MD	MD	NNP	I-NP	O
INTERIM	INTERIM	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Cardiology	Cardiology	NNP	B-NP	O
Tuc	Tuc	NNP	I-NP	O
Pla	Pla	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	I-NP	O
flutter	flutter	NN	I-NP	O
.	.	.	O	O

LIST	LIST	NN	B-NP	O
OF	OF	IN	B-PP	O
PROBLEMS	PROBLEMS	NNP	B-NP	O
AND	AND	CC	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Insulin-dependent	Insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
77-year-old	77-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
in	in	IN	B-PP	O
2000	2000	CD	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
4	4	CD	B-NP	O
cardioversions	cardioversion	NNS	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
until	until	IN	B-PP	O
January	January	NNP	B-NP	O
2005	2005	CD	I-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
skin	skin	NN	B-NP	O
discoloration	discoloration	NN	I-NP	O
;	;	:	O	O
since	since	IN	B-PP	O
then	then	RB	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
Toprol	Toprol	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
has	have	VBZ	B-VP	O
done	do	VBN	I-VP	O
well	well	RB	B-ADVP	O
since	since	IN	B-PP	O
a	a	DT	B-NP	O
stent	stent	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
in	in	IN	B-PP	O
2002	2002	CD	B-NP	O
,	,	,	O	O
not	not	RB	O	O
requiring	require	VBG	B-VP	O
any	any	DT	B-NP	O
hospitalizations	hospitalization	NNS	I-NP	O
for	for	IN	B-PP	O
cardiac-related	cardiac-related	JJ	B-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
July	July	NNP	B-NP	O
2006	2006	CD	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
notes	note	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
feel	feel	VB	I-VP	O
weak	weak	JJ	B-ADJP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	O	O
occasional	occasional	JJ	B-NP	O
palpitations	palpitation	NNS	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
he	he	PRP	B-NP	B-protein
denied	deny	VBD	B-VP	I-protein
any	any	DT	B-NP	I-protein
chest	ch	JJS	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
continuation	continuation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Toprol	Toprol	NN	I-NP	O
for	for	IN	B-PP	O
rate	rate	NN	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
cardioverted	cardioverte	VBN	I-VP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
2006	2006	CD	I-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
symptomatic	symptomatic	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
until	until	IN	B-PP	O
January	January	NNP	B-NP	O
2006	2006	CD	I-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
again	again	RB	B-ADVP	O
reportedly	reportedly	RB	B-ADVP	O
felt	feel	VBD	B-VP	O
weak	weak	JJ	B-ADJP	O
,	,	,	O	O
had	have	VBD	B-VP	O
increased	increase	VBN	I-VP	O
dyspnea	dyspnea	NN	B-NP	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
in	in	IN	B-PP	O
January	January	NNP	B-NP	O
2006	2006	CD	I-NP	O
,	,	,	O	O
showing	show	VBG	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
28	28	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
his	his	PRP$	B-NP	O
increased	increase	VBN	I-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
sudden	sudden	JJ	B-NP	O
death	death	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
single-chamber	single-chamber	JJ	I-NP	O
ICD	ICD	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
feel	feel	VB	I-VP	O
even	even	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
unwell	unwell	JJ	I-ADJP	O
towards	towards	IN	B-PP	O
the	the	DT	B-NP	O
later	later	JJ	I-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-ADVP	O
these	these	DT	B-NP	O
were	be	VBD	B-VP	O
his	his	PRP$	B-NP	O
typical	typical	JJ	I-NP	O
angina	angina	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Consequently	Consequently	RB	B-ADVP	O
,	,	,	O	O
ETT	ETT	NN	B-NP	B-protein
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
on	on	IN	B-PP	O
9/18/2006	9/18/2006	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
terminated	terminate	VBN	I-VP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
minute	minute	NN	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
went	go	VBD	B-VP	O
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
130	130	CD	B-NP	O
.	.	.	O	O

Electrophysiology	Electrophysiology	NN	B-NP	O
adjusted	adjust	VBD	B-VP	O
his	his	PRP$	B-NP	O
ICD	ICD	NN	I-NP	B-protein
,	,	,	O	O
still	still	RB	B-ADVP	O
he	he	PRP	B-NP	O
reports	report	VBZ	B-VP	O
continued	continue	VBN	B-NP	O
symptoms	symptom	NNS	I-NP	O
as	as	IN	B-SBAR	O
previously	previously	RB	B-ADVP	O
described	describe	VBN	B-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
decreased	decrease	VBN	B-NP	O
appetite	appetite	NN	I-NP	O
and	and	CC	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
pounds	pound	NNS	I-NP	O
over	over	IN	B-PP	O
6	6	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
endorses	endorse	VBZ	B-VP	O
worsening	worsen	VBG	I-VP	O
orthopnea	orthopnea	NN	B-NP	O
and	and	CC	I-NP	O
PND	PND	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
several	several	JJ	I-NP	O
weeks	week	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
on	on	IN	B-PP	O
11/4/2006	11/4/2006	CD	B-NP	O
for	for	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
his	his	PRP$	B-NP	O
worsening	worsen	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Gabard	Gabard	NNP	I-NP	O
's	's	POS	B-NP	O
clinic	clinic	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
consideration	consideration	NN	B-NP	O
of	of	IN	B-PP	O
options	option	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

PREADMISSION	PREADMISSION	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	O
XL	XL	NN	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Diovan	Diovan	NNP	B-NP	O
160	160	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
,	,	,	O	O
Saturday	Saturday	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Sunday	Sunday	NNP	B-NP	O
;	;	:	O	O
7.5	7.5	CD	B-NP	O
mg	mg	NN	I-NP	O
on	on	IN	B-PP	O
Tuesday	Tuesday	NNP	B-NP	O
and	and	CC	O	O
Thursday	Thursday	NNP	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	RB	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

K-Dur	K-Dur	NN	B-NP	O
10	10	CD	I-NP	O
mEq	mEq	NN	I-NP	O
every	every	DT	B-NP	O
Monday	Monday	NNP	B-NP	O
and	and	CC	O	O
Friday	Friday	NNP	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Zetia	Zetia	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Pravachol	Pravachol	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Glyburide/metformin	Glyburide/metformin	NN	B-NP	O
2-5/500	2-5/500	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
24	24	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Elavil	Elavil	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Vitamin	Vitamin	NNP	B-NP	O
C.	C.	NNP	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Vitamin	Vitamin	NN	B-NP	O
B12	B12	NN	I-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Magnesium	Magnesium	NN	B-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Zinc	Zinc	NN	B-NP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Folic	Folic	JJ	B-NP	O
acid	acid	NN	I-NP	O
.	.	.	O	O

20	20	CD	B-NP	O
.	.	.	O	O

Coenzyme	Coenzyme	NN	B-NP	O
Q10	Q10	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Tota	Tota	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
retired	retired	JJ	I-NP	O
lobbyist	lobbyist	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
currently	currently	RB	B-ADVP	O
lives	live	VBZ	B-VP	O
in	in	IN	B-PP	O
Jo	Jo	NNP	B-NP	O
Car	Car	NNP	I-NP	O
Mont	Mont	NNP	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
smoke	smoke	VB	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
drink	drink	VB	I-VP	O
excessively	excessively	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
occasional	occasional	JJ	I-NP	O
glass	glass	NN	I-NP	O
of	of	IN	B-PP	O
wine	wine	NN	B-NP	O
or	or	CC	O	O
two	two	CD	B-NP	O
at	at	IN	B-PP	O
dinnertime	dinnertime	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
brother	brother	NN	B-NP	O
who	who	WP	B-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
58	58	CD	I-NP	O
,	,	,	O	O
father	father	NN	B-NP	O
who	who	WP	B-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
78	78	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
mother	mother	NN	B-NP	O
with	with	IN	B-PP	O
atherosclerosis	atherosclerosis	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Flagyl	Flagyl	NN	B-NP	O
to	to	TO	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
gets	get	VBZ	B-VP	O
edema	edema	NN	B-NP	O
and	and	CC	I-NP	O
Demerol	Demerol	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Vitals	Vital	NNS	B-NP	O
were	be	VBD	B-VP	O
temperature	temperature	NN	B-NP	O
of	of	IN	B-PP	O
95.7	95.7	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
80	80	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
144/78	144/78	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Generally	Generally	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
comfortable-at-rest-appearing	comfortable-at-rest-appearing	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
shows	show	VBZ	B-VP	O
JVP	JVP	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
7	7	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
exam	exam	NN	I-NP	O
is	be	VBZ	B-VP	O
irregularly	irregularly	RB	B-ADJP	O
irregular	irregular	JJ	I-ADJP	O
with	with	IN	B-PP	O
abnormal	abnormal	JJ	B-NP	O
S1	S1	NN	I-NP	O
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
soft	soft	JJ	B-NP	O
S3	S3	NN	I-NP	O
.	.	.	O	O

Soft	Soft	JJ	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
S4	S4	NN	I-NP	B-protein
or	or	CC	I-NP	O
rub	rub	NN	I-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
heave	heave	NN	I-NP	O
or	or	CC	O	O
palpable	palpable	JJ	B-NP	O
thrill	thrill	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
is	be	VBZ	B-VP	O
obese	obese	JJ	B-ADJP	O
,	,	,	O	O
mildly	mildly	RB	B-NP	O
tender	tender	NN	I-NP	O
without	without	IN	B-PP	O
hepatosplenomegaly	hepatosplenomegaly	NN	B-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
are	be	VBP	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
from	from	IN	B-PP	O
ankles	ankle	NNS	B-NP	O
to	to	TO	B-PP	O
thighs	thigh	NNS	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
neuro	neuro	JJ	I-NP	O
exam	exam	NN	I-NP	O
is	be	VBZ	B-VP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
137	137	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
5.2	5.2	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
33	33	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.6	1.6	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
218	218	CD	I-NP	O
.	.	.	O	O

ALT	ALT	NN	B-NP	B-protein
26	26	CD	I-NP	I-protein
,	,	,	O	O
AST	AST	NN	B-NP	O
29	29	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.3	0.3	CD	I-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
66	66	CD	I-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
659	659	CD	I-NP	I-protein
.	.	.	O	O

White	White	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
599	599	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
39.3	39.3	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
196	196	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Lipids	Lipid	NNS	B-NP	O
:	:	:	O	O
Total	Total	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
121	121	CD	I-NP	O
,	,	,	O	O
triglycerides	triglyceride	NNS	B-NP	O
166	166	CD	B-NP	O
,	,	,	O	O
HDL	HDL	NN	B-NP	B-DNA
37	37	CD	I-NP	I-DNA
,	,	,	O	O
LDL	LDL	NN	B-NP	O
51	51	CD	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
70s	70	NNS	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
intervals	interval	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
ST	ST	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
,	,	,	O	O
10/27/2006	10/27/2006	CD	B-NP	O
:	:	:	O	O
Ejection	Ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
ventricular	ventricular	JJ	I-NP	O
diameter	diameter	NN	I-NP	O
,	,	,	O	O
end-diastole	end-diastole	NN	B-NP	O
,	,	,	O	O
6.2	6.2	CD	B-NP	O
%	%	NN	I-NP	O
;	;	:	O	O
end-systole	end-systole	NN	B-NP	O
4.8	4.8	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Septum	Septum	NNP	B-NP	O
is	be	VBZ	B-VP	O
thin	thin	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
akinetic	akinetic	JJ	I-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
hypokinetic	hypokinetic	JJ	I-NP	O
mid	mid	NN	I-NP	O
to	to	TO	B-PP	O
distal	distal	JJ	B-NP	O
wall	wall	NN	I-NP	O
,	,	,	O	O
posterior	posterior	JJ	B-NP	O
and	and	CC	I-NP	O
inferior	inferior	JJ	I-NP	O
wall	wall	NN	I-NP	O
.	.	.	O	O

Mild	Mild	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
and	and	CC	O	O
tricuspid	tricuspid	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
dilated	dilated	JJ	I-NP	O
aortic	aortic	JJ	I-NP	O
root	root	NN	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
x-ray	x-ray	NN	I-NP	O
,	,	,	O	O
10/27/2006	10/27/2006	CD	B-NP	O
,	,	,	O	O
shows	show	VBZ	B-VP	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
interstitial	interstitial	JJ	I-NP	O
process	process	NN	I-NP	O
and	and	CC	B-PP	O
without	without	IN	B-PP	O
effusions	effusion	NNS	B-NP	O
.	.	.	O	O

PROCEDURES	PROCEDURES	NNS	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
2/25/2006	2/25/2006	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
dofetilide	dofetilide	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
Heart	Heart	NNP	I-NP	O
Failure	Failure	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
diuretic	diuretic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
by	by	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
presentation	presentation	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
compensated	compensate	VBN	I-VP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.6	1.6	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
daily	daily	JJ	I-NP	O
goal	goal	NN	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
was	be	VBD	B-VP	O
-2	-2	CD	B-NP	O
to	to	TO	B-PP	O
2.5	2.5	CD	B-NP	O
L	L	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-PP	O
in	in	IN	I-PP	O
and	and	CC	I-PP	O
out	out	IN	I-PP	O
goal	goal	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
over	over	RP	B-PRT	O
to	to	TO	B-PP	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
on	on	IN	B-PP	O
10/20/2006	10/20/2006	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Toprol	Toprol	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
in-house	in-house	JJ	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
his	his	PRP$	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
increases	increase	NNS	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
restart	restart	VB	I-VP	O
his	his	PRP$	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
following	follow	VBG	B-PP	O
complete	complete	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
to	to	TO	B-PP	O
dry	dry	JJ	B-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
or	or	CC	I-NP	O
signs	sign	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
in-house	in-house	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Zetia	Zetia	NN	I-NP	O
for	for	IN	B-PP	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
Fibrillation	Fibrillation	NN	I-NP	O
:	:	:	O	O
Given	Give	VBN	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	I-NP	O
flutter	flutter	NN	I-NP	O
since	since	IN	B-PP	O
2000	2000	CD	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
continued	continue	VBN	I-NP	O
symptoms	symptom	NNS	I-NP	O
on	on	IN	B-PP	O
Toprol	Toprol	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
amiodarone	amiodarone	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
an	an	DT	B-NP	O
option	option	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
wished	wish	VBD	B-VP	O
to	to	TO	I-VP	O
pursue	pursue	VB	I-VP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
side	side	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
skin	skin	NN	B-NP	O
discoloration	discoloration	NN	I-NP	O
that	that	IN	B-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
previously	previously	RB	I-VP	O
experienced	experience	VBN	I-VP	O
-RRB-	-RRB-	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
to	to	TO	I-VP	O
proceed	proceed	VB	I-VP	O
with	with	IN	B-PP	O
dofetilide	dofetilide	NN	B-NP	O
therapy	therapy	NN	I-NP	O
on	on	IN	B-PP	O
10/20/2006	10/20/2006	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
QTc	QTc	NN	I-NP	B-protein
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
this	this	DT	B-NP	O
process	process	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
plan	plan	NN	I-NP	O
was	be	VBD	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
transesophageal	transesophageal	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
and	and	CC	I-NP	O
DC	DC	NN	I-NP	B-cell_type
cardioversion	cardioversion	NN	I-NP	O
on	on	IN	B-PP	O
8/7/2006	8/7/2006	CD	B-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
in-house	in-house	JJ	B-ADVP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
between	between	IN	B-PP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
3	3	CD	B-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
achieve	achieve	VB	I-VP	O
this	this	DT	B-NP	O
goal	goal	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Insulin-Dependent	Insulin-Dependent	JJ	B-NP	O
Diabetes	Diabetes	NNP	I-NP	O
Mellitus	Mellitus	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
off	off	RP	B-PRT	O
oral	oral	JJ	B-NP	O
hypoglycemics	hypoglycemic	NNS	I-NP	O
in-house	in-house	JJ	B-ADJP	O
but	but	CC	O	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
24	24	CD	I-NP	O
units	unit	NNS	I-NP	O
before	before	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
an	an	DT	B-NP	O
insulin	insulin	NN	I-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
addendum	addendum	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
summary	summary	NN	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Gil	Gil	NNP	I-NP	O
Ciciora	Ciciora	NNP	I-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
3-3270941	3-3270941	CD	B-NP	O
HFFocus	HFFocus	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
DEMOURA	DEMOURA	NN	B-NP	O
,	,	,	O	O
LOUIS	LOUIS	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
PEARYER	PEARYER	NNP	B-NP	O
,	,	,	O	O
ELMER	ELMER	NNP	B-NP	O
ALEX	ALEX	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
1457076	1457076	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
6/28/06	6/28/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/7/06	7/7/06	CD	B-NP	O

